24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
30/04/2015
The Library Living Lab opens its doors
23/04/2015
8 million Euros turnover for the Start-ups settled in the PRUAB
16/04/2015
The BSP opens its new head office
09/04/2015
Three important projects awarded to SENER
25/03/2015
ALBA synchrotron supports the pharmaceutical industry
20/03/2015
Barcelona named top smart city in the world